FDA Approves Alembic Pharma’s Generic Alternative to Synthroid
Alembic Pharmaceuticals Limited has secured a major regulatory victory, receiving final approval from the US Food and Drug Administration (USFDA) for its generic levothyroxine sodium tablets. The approval clears the way for the company to market its drug across a comprehensive range of twelve different strengths, stretching from 25 mcg up to 300 mcg. According…
